Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Olema Pharmaceuticals Inc (NQ: OLMA ) 12.19 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Olema Pharmaceuticals Inc < Previous 1 2 3 4 5 6 Next > Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023 February 22, 2023 Via Benzinga Olema Oncology to Participate at Upcoming Investor Conferences February 21, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 02, 2023 From Olema Oncology Via GlobeNewswire Olema Pharma Says Lead Candidate Robust Activity In Breast Cancer Patients October 26, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 17, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 12, 2023 Via Benzinga CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks January 06, 2023 Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. Via Investor's Business Daily Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 04, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference January 03, 2023 From Olema Oncology Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session December 07, 2022 Via Benzinga Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation Study December 07, 2022 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 02, 2022 From Olema Oncology Via GlobeNewswire Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS) November 21, 2022 From Olema Oncology Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session November 15, 2022 Via Benzinga Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 08, 2022 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 02, 2022 From Olema Oncology Via GlobeNewswire Olema Oncology to Present at Upcoming Investor Conferences in November November 01, 2022 From Olema Oncology Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session October 31, 2022 Gainers PLx Pharma (NASDAQ:PLXP) stock increased by 15.5% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $20.3 million. Via Benzinga Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical Trial October 26, 2022 From Olema Oncology Via GlobeNewswire Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics October 12, 2022 From Olema Oncology Via GlobeNewswire Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday October 21, 2022 Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday October 10, 2022 We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them! Via InvestorPlace Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 04, 2022 From Olema Oncology Via GlobeNewswire Recap of Tuesday's Biotech Catalysts - End Of the Day Summary August 09, 2022 Via Benzinga Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners July 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday August 11, 2022 Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. Via Benzinga This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday July 25, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 21, 2022 Via Benzinga This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday July 22, 2022 Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period... Via Benzinga Olema Oncology Shares Ascend As FDA Grants Fast Track Status To Breast Cancer Candidate July 21, 2022 The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Olema Oncology’s (NASDAQ: OLMA) lead asset OP-1250 for the treatment of ER-positive (ER+), human epidermal growth... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.